Atlas Trials

The Exploratory Study on the Baseline Level of NAD+/NADH in Peripheral Blood Samples of Different Gender and Age Groups of Healthy Adults.

Clinical trial NCT05997628 · UNKNOWN

Trial details

NCT number
NCT05997628
Sponsor
Shanghai Cell Therapy Group Co.,Ltd
Status
UNKNOWN
Study type
OBSERVATIONAL
NAD+/NADH in Peripheral Blood Monitoring
Start date
2023-08-01
Primary completion
2024-05-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.